In this work, a highly sensitive flexible glucose sensor based on a field effect transistor (FET) has been fabricated. It is shown that the proposed flexible transistor can be used as new non-enzymatic blood glucose test strips. CuO hollow-spheres decorated with reduced graphene oxide have been synthesized using the hydrothermal method. The shells of the hollow micro-spheres are formed by nanostructures. The synthesized nanostructured hollow micro-spheres (rGO/CuO-NHS) are deposited on a flexible PET substrate between interdigitated electrodes as the channel of a back gate transistor. The channel concentration and the FET bias are optimized so that the sensor exhibits extremely low limit of detection and high sensitivity. The combination of selective porous CuO hollow spheres and the high surface to volume ratio of their nanostructured shells with the high mobility and high conductivity rGO led to faster and higher charge-transfer capability and superior electro-catalyst activity for glucose oxidation. The glucose-dependent electrical responses of the sensor is measured in both resistive and transistor action modes. The amplification of the current by the induced electric field of the gate in the proposed FET-based biosensor provides advantages such as higher sensitivity and lower limit of detection compared to the resistive sensor. The flexible glucose sensor has a sensitivity of 600 μA μM and a limit of detection of 1 nM with high reproducibility, good stability, and highly selectivity. The high accuracy response of the biosensor towards the real blood serum samples showed that it can be used as a test strip for glucose detection in real blood samples.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763381 | PMC |
http://dx.doi.org/10.1038/s41598-022-26287-8 | DOI Listing |
Genet Med
January 2025
Newborn Screening Ontario, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada; Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa. Electronic address:
Purpose: Universal newborn hearing screening (UNHS) programs using audiometric techniques alone are limited in ability to detect non-congenital childhood permanent hearing loss (PHL). In 2019, Ontario launched universal newborn screening (NBS) for PHL risk factors: congenital cytomegalovirus (cCMV) and 22 common variants in GJB2 and SLC26A4. Here we describe our experience with genetic risk factor screening.
View Article and Find Full Text PDFCancer Med
January 2025
Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.
Background And Aim: In recent years, there has been a rise in cryptogenic hepatocellular carcinoma (c-HCC) cases in Japan, posing a detection challenge due to an unknown etiology. This study aims to enhance diagnostic strategies for c-HCC by analyzing its characteristics and exploring current opportunities for detection.
Methods: A retrospective study was conducted from April 2012 to March 2022, enrolling 372 newly diagnosed hepatocellular carcinoma (HCC) patients.
ACR Open Rheumatol
January 2025
Duke University and Duke Clinical Research Institute, Durham, North Carolina.
Objective: The objective of this study was to evaluate the preliminary effectiveness of an electronic pill bottle with automated reminders on hydroxychloroquine (HCQ) adherence in children with pediatric systemic lupus erythematosus (pSLE).
Methods: This was a self-controlled, open label, direct-to-family pilot trial. Children with pSLE treated with HCQ were recruited from the Childhood Arthritis and Rheumatology Research Alliance Registry.
Arterioscler Thromb Vasc Biol
January 2025
School of Life Science, Nantong Laboratory of Development and Diseases and Co-Innovation Center of Neuroregeneration, Nantong University, China.
Background: Sprouting blood vessels, reaching the aimed location, and establishing the proper connections are vital for building vascular networks. Such biological processes are subject to precise molecular regulation. So far, the mechanistic insights into understanding how blood vessels grow to the correct position are limited.
View Article and Find Full Text PDFAfr J Prim Health Care Fam Med
December 2024
Department of Internal Medicine, Prince Mshiyeni Memorial Hospital, Durban.
Background: Tuberculosis (TB) remains a leading cause of mortality in low-resource settings and poses a diagnostic challenge in human immunodeficiency virus (HIV)-negative populations because of limitations in traditional diagnostic methods such as sputum smear microscopy (SSM) and sputum Xpert Ultra. There is a lack of effective, non-invasive diagnostic options for TB diagnosis in HIV-negative populations. This scoping review explores the potential of urinary lipoarabinomannan (ULAM) as a point-of-care diagnostic tool for Mycobacterium tuberculosis (MTB) in HIV-negative individuals.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!